Cydex Pharmaceuticals, Inc.
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
25
Ending by 2030
Nov 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 18, 2026The maintenance fee for Alkylated cyclodextrin compositions and processes for preparing and using the same (US 10,323,103) comes due Dec 18, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due Mar 8, 2027The maintenance fee for Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use (US 9,125,945) comes due Mar 8, 2027. Unpaid by Sep 8, 2027, it lapses early.
- 1 fee due Apr 24, 2027The maintenance fee for Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same (US 11,795,241) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
- 2 fees due May 5 to 7, 2027 · next May 5
- 2 fees due Jun 1 to 24, 2027 · next Jun 1
- 1 fee due Oct 28, 2027The maintenance fee for Manufacturing process for cyclodextrin derivatives (US 10,633,462) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,846,901 | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,049,003 | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,668,160 | DPI formulation containing sulfoalkyl ether cyclodextrin In force · From the USPTO record | In force | From the USPTO record | |
| US 12,370,352 | Nasal and ophthalmic delivery of aqueous corticosteroid solutions In force · From the USPTO record | In force | From the USPTO record | |
| US 8,114,438 | Dpi Formulation Containing Sulfoalkyl Ether Cyclodextrin In force · Low confidence | In force | Low confidence | |
| US 8,853,236 | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use In force · From the USPTO record | In force | From the USPTO record | |
| US 9,125,945 | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use In force · From the USPTO record | In force | From the USPTO record | |
| US 9,623,045 | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use In force · From the USPTO record | In force | From the USPTO record | |
| US 10,034,947 | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use In force · From the USPTO record | In force | From the USPTO record | |
| US 10,512,697 | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 41: 3 patents in force now held by others · 17 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 3 abandoned · 9 no status recorded